WARRIOR Underscores Burden of Nonobstructive Angina in Women

In women with signs of ischemia but no obstructive coronary artery disease (OCAD), intensive medical therapy did not reduce the first occurrence of a major cardiovascular event in the WARRIOR trial, but the trial was underpowered to show a definitive result. “This is a neutral trial and should not be considered a negative trial,” said … Read more

Study finds high rates of undiagnosed and untreated peripheral artery disease

A new Intermountain Health study finds that peripheral artery disease, a condition that affects more than 10 million Americans over the age of 40, is often underdiagnosed and undertreated, with fewer women getting guideline-directed medical therapy than men. As a result, combined with this highly debilitating disease, patients with peripheral artery disease have a more … Read more

Combination therapy could prevent thousands of cardiovascular deaths

The largest analysis to examine the best way to lower levels of ‘bad’ cholesterol in patients with blocked arteries shows that they should immediately be given a combination of a statin and another drug called ezetimibe, rather than statins alone. This could prevent thousands of deaths a year from heart attacks, strokes and other cardiovascular … Read more

Cardiovascular Risk in T1D: LDL Focus and Beyond

Estimation of cardiovascular risk (CVR) in individuals living with type 1 diabetes (T1D) was a key topic presented by Sophie Borot, MD, from Besançon University Hospital, Besançon, France, at the 40th congress of the French Society of Endocrinology. Borot highlighted the complexities of this subject, outlining several factors that contribute to its challenges. A Heterogeneous … Read more